NY S02625 | 2015-2016 | General Assembly

Status

Spectrum: Partisan Bill (Democrat 2-0)
Status: Introduced on January 27 2015 - 25% progression, died in committee
Action: 2016-02-01 - PRINT NUMBER 2625A
Pending: Senate Health Committee
Text: Latest bill text (Amended) [HTML]

Summary

Requires manufacturers and labelers of prescription drugs dispensed in this state which engage in marketing activities in the state to annually report marketing expenses to the department of health; imposes a $10,000 civil fine for failure to report; eliminates deductibility for certain expenses incurred in the advertising of prescription drugs.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Requires manufacturers and labelers of prescription drugs dispensed in this state which engage in marketing activities in the state to annually report marketing expenses to the department of health; imposes a $10,000 civil fine for failure to report; eliminates deductibility for certain expenses incurred in the advertising of prescription drugs.

Sponsors


History

DateChamberAction
2016-02-01SenatePRINT NUMBER 2625A
2016-02-01SenateAMEND AND RECOMMIT TO HEALTH
2016-01-06SenateREFERRED TO HEALTH
2015-01-27SenateREFERRED TO HEALTH

New York State Sources


Bill Comments

feedback